Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage

Molecular and Cellular Biochemistry

Volumn 317, Issue 1-2, 2008, Pages 11-20

  Sudhahar, V ^a   Ashok Kumar, S ^a   Varalakshmi, P ^a   Sujatha, V ^b  

^a UNIVERSITY OF MADRAS   (India)

^b KAP Viswanathan Government Medical College   (India)

Author keywords

Hypercholesterolemia; Oxidative and inflammatory stress; Renal damage; Triterpene

Indexed keywords

ACETYLGLUCOSAMINIDASE; ACID PHOSPHATASE; ALBUMIN; ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; BETA GLUCURONIDASE; C REACTIVE PROTEIN; CATHEPSIN; CHOLESTEROL; CREATININE; FIBRINOGEN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; LINOLEIC ACID; LUPEOL; LUPEOL LINOLEATE; PHOSPHOLIPID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INFLAMMATION; KIDNEY INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PHOSPHOLIPID BLOOD LEVEL; RAT; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; C-REACTIVE PROTEIN; DIETARY FATS; HYDROLASES; HYPERCHOLESTEROLEMIA; KIDNEY DISEASES; LIPID PEROXIDATION; LIPIDS; LYSOSOMES; MALE; PHYTOTHERAPY; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TRITERPENES;

RATTUS; RATTUS NORVEGICUS;

EID: 53149141375     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9786-5     Document Type: Article

References (69)

1. Ishiyama A, Atarashi K, Minami M, Takagi M, Kimura K, Goto A et al (1999) Role of free radicals in the pathogenesis of lipid-induced glomerulosclerosis in rats. Kidney Int 55:1348-1358. doi: 10.1046/ j.1523-1755.1999.00364.x
2. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340:1430-1432. doi: 10.1016/ 0140-6736(92)92621-L
3. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA (1993) The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88:2541-2547
4. Romero R, Higueruelo S, Vaquero M, Biosca C, Martínez-Ocaña JC, Pastor C (1998) Effects of polyunsaturated fatty acids on rat glomerulosclerosis induced by hypercholesterolaemic diet. Res Exp Med (Berl) 198:1-10. doi: 10.1007/s004330050084
5. Oda H, Keane WF (1999) Recent advances in statins and the kidney. Kidney Int Suppl 71:S2-S5. doi: 10.1046/j.1523-1755.1999.07101.x
6. Deepa PR, Varalakshmi P (2006) Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative. Int J Cardiol 106:338-347. doi: 10.1016/ j.ijcard.2005.02.012
7. Scheuer H, Gwinner W, Hohbach J, Grone EF, Brandes RP, Malle E et al (2000) Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol 278:F63-F74
8. Schmitz G, Langmann T (2006) Pharmacogenomics of cholesterol-lowering therapy. Vascul Pharmacol 44:75-89. doi: 10.1016/j.vph.2005.07.012
9. Baskar R, Meenalakshmi Malini M, Varalakshmi P, Balakrishna K, Bhima Rao R (1996) Effect of lupeol isolated from Crataeva nurvala stem bark against free radical-induced toxicity in experimental urolithiasis. Fitoterapia 67:121-126
10. Geetha T, Varalakshmi P (1998) Anti-inflammatory activity of lupeol and lupeol linoleate in Adjuvant-induced arthritis. Fitoterapia 69:13-19
11. Sudharsan PT, Mythili Y, Sudhahar V, Varalakshmi P (2005) Role of lupeol and its ester on cyclophosphamide-induced hyperlipidaemic cardiomyopathy in rats. J Pharm Pharmacol 57:1437-1444. doi: 10.1211/jpp.57.11.0009
12. Nikiema JB, Vanhaelen-Fastre R, Vanhaelen M, Fontaine J, De Graef C, Heenen M (2001) Effects of antiinflammatory triterpenes isolated from Leptadenia hastata latex on keratinocyte proliferation. Phytother Res 15:131-134. doi: 10.1002/ptr.700
13. Sudhahar V, Kumar SA, Varalakshmi P (2006) Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci 78:1329-1335. doi: 10.1016/ j.lfs.2005.07.011
14. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
15. Parekh AC, Jung DH (1970) Cholesterol determination with ferric acetate-uranium acetate and sulfuric acid-ferrous sulphate reagents. Anal Chem 42:1423-1427. doi: 10.1021/ac60294a044
16. Rice EW (1970) Triglycerides ("neutral fats") in serum. In: MacDonald PR (ed) Standard methods of clinical chemistry, vol 6. Academic press, New York, pp 215-222
17. Hron WT, Menahan LA (1981) A sensitive method for the determination of free fatty acids in plasma. J Lipid Res 22:377-381
18. Rouser G, Fkeischer S, Yamamoto A (1970) Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496. doi: 10.1007/BF02531316
19. Reinhold JG (1953) Total protein albumin and globulin. In: Seligson D (ed) Standard methods of clinical chemistry, vol 1. Academic press, New York, p 88
20. Natelson S, Scott ML, Beffa C (1951) A rapid method for the estimation of urea in biologic fluids. Am J Clin Pathol 21:275-281
21. Caraway WT (1963) Uric acid. In: Seligson D (ed) Standard methods of clinical chemistry, vol 1. Academic press, New York, pp 239-247
22. Owen JA, Iggo B, Scandrett FJ, Stewart CP (1954) The determination of creatinine in plasma or serum, and in urine; a critical examination. Biochem J 58:426-437
23. King J (1965) The dehydrogenases or oxidoreductases - lactate dehydrogenase. In: Van D (ed) Practical clinical enzymology. Nostrand Company Ltd, London, pp 83-93
24. King J (1965) The hydrolases- acid and alkaline phosphatises. In: Van D (ed) Practical clinical enzymology. Nostrand Company Ltd, London, pp 191-208
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
26. Högberg J, Larson RE, Kristoferson A, Orrenius S (1974) NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem Biophys Res Commun 56:836-842. doi: 10.1016/ 0006-291X(74)90681-0
27. Devasagayam TP (1986) Lipid peroxidation in rat uterus. Biochim Biophys Acta 876:507-514
28. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474. doi: 10.1111/ j.1432-1033.1974.tb03714.x
29. Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389-394. doi: 10.1016/0003-2697(72)90132-7
30. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: Biochemical role as a component of glutathione peroxidase. Science 179:588-590. doi: 10.1126/science.179.4073.588
31. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78
32. Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62:3-11. doi: 10.1016/0076-6879(79)62181-X
33. Desai ID (1984) Vitamin E analysis methods for animal tissues. Methods Enzymol 105:138-147. doi: 10.1016/S0076-6879(84)05019-9
34. Maruhn D (1976) Rapid colorimetric assay of beta-galactosidase and N -acetyl-beta-glucosaminidase in human urine. Clin Chim Acta 73:453-461. doi: 10.1016/0009-8981(76)90147-9
35. Kawai Y, Anno K (1971) Mucopolysaccharide-degrading enzymes from the liver of the squid, Ommastrephes sloani pacificus. I. Hyaluronidase. Biochim Biophys Acta 242:428-436
36. Etherington DJ (1972) The nature of the collagenolytic cathepsin of rat liver and its distribution in other rat tissues. Biochem J 127:685-692
37. Lempert HC (1969) Determination of plasma protein. In: Varley H (ed) Practical clinical biochemistry, 4th edn. CBS Publishers, New Delhi, p 233
38. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143. doi: 10.1161/hc0902.104353
39. Hattori M, Nikolic-Paterson DJ, Miyazaki K, Isbel NM, Lan HY, Atkins RC, Kawaguchi H, Ito K (1999) Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Kidney Int Suppl 71:S47-S50
40. Sudhahar V, Kumar SA, Varalakshmi P, Sundarapandiyan R (2007) Mitigating role of lupeol and lupeol linoleate on hepatic lipemic-oxidative injury and lipoprotein peroxidation in experimental hypercholesterolemia. Mol Cell Biochem 295:189-198
41. Napoli C, Lerman LO (2001) Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc 76:619-631
42. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, Pelaez LI, Grande JP, Ritman EL, Lerman LO (2002) Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int 61:1056-1063
43. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO (2002) Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106:1165-1171
44. Salil G, Rajamohan T (2001) Hypolipidemic and antiperoxidative effect of coconut protein in hypercholesterolemic rats. Indian J Exp Biol 39:1028-1034
45. Fungwe TV, Cagen LM, Cook GA, Wilcox HG, Heimberg M (1993) Dietary cholesterol stimulates hepatic biosynthesis of triglyceride and reduces oxidation of fatty acids in the rat. J Lipid Res 34:933-941
46. Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352:670-671
47. Beard JT 2nd (1983) Serum uric acid and coronary heart disease. Am Heart J 106:397-400
48. Alderman M, Aiyer KJ (2004) Uric acid: Role in cardiovascular disease and effects of losartan. Curr Med Res Opin 20:369-379
49. Deepa PR, Varalakshmi P (2004) Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin Chim Acta 339:105-115
50. Naik SR, Sheth UK (1978) Studies on two new derivatives of N -aralkyl-o-ethoxybenzamides: Part II - biochemical studies on their anti-inflammatory activity. Indian J Exp Biol 16:1175-1179
51. Fernandez MA, de las Heras B, Garcia MD, Saenz MT, Villar A (2001) New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 53:1533-1539
52. Halliwell B (1996) Mechanisms involved in the generation of free radicals. Pathol Biol (Paris) 44:6-13
53. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551
54. Grone EF, Walli AK, Grone HJ, Miller B, Seidel D (1994) The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 107:1-13
55. Yamashita K, Lu H, Lu J, Chen G, Yokoyama T, Sagara Y, Manabe M, Kodama H (2002) Effect of three triterpenoids, lupeol, betulin, and betulinic acid on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophils. Clin Chim Acta 325:91-96
56. de Duve C (1974) The participation of lysosomes in the transformation of smooth muscle cells to foamy cells in the aorta of cholesterol-fed rabbits. Acta Cardiol 20:9-25
57. De Duve C, Wattiaux R (1966) Functions of lysosomes. Annu Rev Physiol 28:435-492
58. Miller BF, Kothari HV (1969) Increased activity of lysosomal enzymes in human atherosclerotic aortas. Exp Mol Pathol 10:288-294
59. Zemplenyi T, Tidwell DF, Fronek K (1984) Aortic enzymes and lactate in high altitude-raised and cholesterol-fed rabbits. Atherosclerosis 52:233-242
60. Agha AM, Gad MZ (1995) Lipid peroxidation and lysosomal integrity in different inflammatory models in rats: The effects of indomethacin and naftazone. Pharmacol Res 32:279-285
61. Geetha T, Varalakshmi P (1999) Effect of lupeol and lupeol linoleate on lysosomal enzymes and collagen in adjuvant-induced arthritis in rats. Mol Cell Biochem 201:83-87
62. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314:488-500
63. Saadeddin SM, Habbab MA, Ferns GA (2002) Markers of inflammation and coronary artery disease. Med Sci Monit 8:RA5-RA12
64. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group. Fragmin during instability in coronary artery disease. N Engl J Med 343:1139-1147
65. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165-2168
66. Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531-2534
67. Ernst E (1990) Plasma fibrinogen - an independent cardiovascular risk factor. J Intern Med 227:365-372
68. Smith EB, Keen GA, Grant A, Stirk C (1990) Fate of fibrinogen in human arterial intima. Arteriosclerosis 10:263-275
69. Campos SB, Ori M, Dorea EL, Seguro AC (1999) Protective effect of l-arginine on hypercholesterolemia-enhanced renal ischemic injury. Atherosclerosis 143:327-334